MyFinsight
Home
Blog
About
Contact
Download
Download image
Deferred income taxes
$40,801K
Accounts receivable, net
-$35,148K
Net income
$24,017K
Share-based compensation
expense
$17,250K
Accounts payable and
accrued expenses
$6,201K
Other liabilities
$3,964K
Proceeds from exercise of
stock options and...
$216K
Depreciation and
amortization
$1,881K
Non-cash lease expense
$1,688K
Non-cash interest
expense
$1,668K
Other assets
-$447K
Prepaid expenses and
other current assets
-$367K
Loss on disposal of
property and equipment
-$89K
Net cash provided by
operating activities
$127,044K
Net cash provided by
(used in) financing...
$216K
Canceled cashflow
$6,477K
Net increase
(decrease) in cash and cash...
$126,897K
Canceled cashflow
$363K
Accrued research and
development costs
-$4,106K
Operating lease
liabilities
-$2,371K
Effect of exchange rate
changes on cash and cash...
-$329K
Net cash used in
investing activities
-$34K
Purchases of property and
equipment
$34K
Back
Back
Cash Flow
source: myfinsight.com
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)